106-107
FINALPhiladelphia
76ers
18-60|L10: 0-10
Sacramento
Kings
27-52|L10: 3-7
-
//
Sports
- All Players
- Seasons
Eastern Conference
Western Conference
More
Sign in
Sign in and connect Sleeper to unlock personalized fantasy insights.
Philadelphia 76ers
Sacramento Kings
| # | Team | W-L | Pct | GB |
|---|---|---|---|---|
| 1 | 56-22 | 0.718 |
| Opponent | Date | Result |
|---|---|---|
| 3/22 | L 87-101 | |
| 3/20 |
| — |
| 2 | 50-27 | 0.649 | 5.5 |
| 3 | 50-28 | 0.641 | 6.0 |
| 4 | 49-31 | 0.613 | 8.0 |
| 5 | 43-34 | 0.558 | 12.5 |
| 6 | 39-39 | 0.500 | 17.0 |
| 7 | 37-42 | 0.468 | 19.5 |
| 8 | 37-42 | 0.468 | 19.5 |
| 9 | 36-45 | 0.444 | 21.5 |
| 10 | 64-91 | 0.413 | 30.5 |
| 11 | 30-49 | 0.380 | 26.5 |
| 12 | 25-53 | 0.321 | 31.0 |
| 13 | 18-60 | 0.231 | 38.0 |
| 14 | 16-61 | 0.208 | 39.5 |
| 15 | 0-0 | 0.000 | 17.0 |
| 3/18 | W 94-83 |
| 3/16 | L 89-108 |
| 3/13 | W 114-107 |
| Opponent | Date | Result |
|---|---|---|
| 3/22 | W 109-86 | |
| 3/20 | W 101-91 | |
| 3/18 | L 105-116 | |
| 3/16 | L 103-110 | |
| 3/13 | L 107-114 |
| Player | PointsPPG | FG% | 3P% | FT% |
|---|---|---|---|---|
| 17.3 | 40.6% | 24.3% | 58.5% | |
| 15.5 | 38.8% | 26.6% | 60.9% | |
| 13.9 | 38.2% | 36.2% | 71.1% |
| Player | PointsPPG | FG% | 3P% | FT% |
|---|---|---|---|---|
| 24.1 |
| 47.4% |
| 3.6% |
| 77.5% |
| 20.8 | 45.5% | 33.9% | 80.7% |
| 15.9 | 48.0% | 33.4% | 69.1% |
| Category | SAC Offense | PHI Defense | Advantage |
|---|---|---|---|
Offensive RatingPoints scored per 100 possessions | #1484.7 ORtg | #12102.6 DRtg | Even |
Turnover RateLower offensive turnovers vs defensive forced turnovers | #2613.0% | #216.1% | SAC |
3P% vs AllowedPerimeter efficiency vs perimeter defense | #2034.2% | #1935.1% | Even |
| Category | SAC Defense | PHI Offense | Advantage |
|---|---|---|---|
Offensive RatingPoints allowed per 100 possessions | #26106.8 DRtg | #2976.2 ORtg | PHI |
Turnover RateDefensive takeaways vs offensive giveaways | #2612.7% | #2913.5% | SAC |
3P% vs AllowedPerimeter defense vs perimeter shooting | #1334.7% | #2832.0% | PHI |